Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03033511 |
|---|---|
| Brief Title: | A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) (MERU) |
| First Submitted : | January 25, 2017 |
| First Submitted that Met QC Criteria : | January 25, 2017 |
| First Posted : | January 26, 2017 (Estimate) |
| Results First Submitted : | November 11, 2020 |
| Results First Posted with QC Comments : | December 7, 2020 |
| Results First Submitted that Met QC Criteria : | December 17, 2020 |
| Results First Posted : | December 21, 2020 |
| Last Update Submitted that Met QC Criteria : | July 28, 2021 |
| Last Update Posted : | July 29, 2021 |